Literature DB >> 16025062

BPPV and variants: improved treatment results with automated, nystagmus-based repositioning.

Meiho Nakayama1, John M Epley.   

Abstract

OBJECTIVE: Although classical benign paroxysmal positional vertigo has generally been resolvable by routine manual repositioning maneuvers, nevertheless resistant cases and variants remain a significant problem. We investigated the efficacy of analyzing and treating positional vertigo with a system that provides unlimited, automated maneuverability of the patient while maintaining constant electronic monitoring of nystagmus. STUDY DESIGN AND
SETTING: A power-driven, multi-axial positioning chair combined with ongoing infrared video-oculography was used to manage 986 subjects in a tertiary clinical setting with complaints of positional vertigo. A nystagmus-based strategy and condition-specific protocols were used.
RESULTS: Significantly enhanced treatment outcomes were achieved, especially regarding intransigent and variant forms. Pertinent correlations were noted.
CONCLUSION: This multi-axial positioning chair combination provided enhanced diagnostic and treatment capabilities for managing positional vertigo, apparently due to improved analytical capability, precision repeatability, and unlimited 360-degree maneuverability. SIGNIFICANCE: This advancement should be considered for tertiary management of complicated labyrinthine lithiasis.

Entities:  

Mesh:

Year:  2005        PMID: 16025062     DOI: 10.1016/j.otohns.2005.03.027

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  14 in total

1.  Repositioning chairs in benign paroxysmal positional vertigo: implications and clinical outcome.

Authors:  Niels West; Søren Hansen; Martin Nue Møller; Sune Land Bloch; Mads Klokker
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-07       Impact factor: 2.503

2.  Causes and characteristics of horizontal positional nystagmus.

Authors:  Corinna Lechner; Rachael L Taylor; Chris Todd; Hamish Macdougall; Robbie Yavor; G Michael Halmagyi; Miriam S Welgampola
Journal:  J Neurol       Date:  2014-03-28       Impact factor: 4.849

3.  Treatment of Benign Paroxysmal Positional Vertigo with the TRV Reposition Chair.

Authors:  Morten Falshoj Pedersen; Helle Hojmark Eriksen; Jonas Bruun Kjaersgaard; Emil Riis Abrahamsen; Dan Dupont Hougaard
Journal:  J Int Adv Otol       Date:  2020-08       Impact factor: 1.017

Review 4.  Clinical significance of cervical and ocular vestibular evoked myogenic potentials in benign paroxysmal positional vertigo: a meta-analysis.

Authors:  Ryohei Oya; Takao Imai; Yukinori Takenaka; Takashi Sato; Kazuo Oshima; Yumi Ohta; Hidenori Inohara
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-11       Impact factor: 2.503

5.  Reposition Chair Treatment Improves Subjective Outcomes in Refractory Benign Paroxysmal Positional Vertigo.

Authors:  Niels West; Sune Land Bloch; Martin Nue Moller; Soren Hansen; Mads Klokker
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

Review 6.  Evidence-based practice: management of vertigo.

Authors:  Anh T Nguyen-Huynh
Journal:  Otolaryngol Clin North Am       Date:  2012-10       Impact factor: 3.346

7.  Benign paroxysmal positional vertigo secondary to laparoscopic surgery.

Authors:  Xizheng Shan; Amy Wang; Entong Wang
Journal:  SAGE Open Med Case Rep       Date:  2017-02-08

Review 8.  Benign paroxysmal positional vertigo in the elderly: current insights.

Authors:  D G Balatsouras; G Koukoutsis; A Fassolis; A Moukos; A Apris
Journal:  Clin Interv Aging       Date:  2018-11-05       Impact factor: 4.458

9.  Update on benign paroxysmal positional vertigo.

Authors:  Hyo-Jung Kim; JaeHan Park; Ji-Soo Kim
Journal:  J Neurol       Date:  2020-11-24       Impact factor: 4.849

10.  Curing a 96-year-old patient afflicted with benign paroxysmal positional vertigo on a motorized turntable.

Authors:  Christopher J Bockisch; Dominik Straumann; Konrad P Weber
Journal:  Clin Interv Aging       Date:  2014-04-08       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.